Angelman Syndrome clinical trials at UCLA
1 in progress, 0 open to eligible people
Showing trials for
Long-term Extension of GTX-102 in Angelman Syndrome
Sorry, accepting new patients by invitation only
The primary objective of the study is to evaluate the long-term safety profile of GTX-102 in participants with Angelman Syndrome (AS)
Los Angeles 5368361, California 5332921 and other locations
Our lead scientists for Angelman Syndrome research studies include Rajsekar R. Rajaraman, MD, MS.